The most prescribed GLP-1RA was semaglutide 1 mg (33%), followed by tirzepatide 7.5 mg (25%)
Bifidobacterium species are generally beneficial, producing short-chain fatty acids, supporting immune function, and helping with nutrient absorption
These CVOT findings are supported by a real-world study performed in over 3 million patients with T2DM from the United States, in which patients treated with SGLT2is did not have a higher risk of any or lower amputation compared with incretins or other glucose-lowering agents [77]
Despite its promise, Retatrutide is still under study in additional trials, such as TRIUMPH-2 and TRIUMPH-3, aimed at understanding its broader health benefits, including its impact on type 2 diabetes and cardiovascular health
Ten were accurate but disclosed a fee or condition only later in the process
WeightWatchers offers a pretty extensive support program